丽珠集团: H股公告：翌日披露报表

Summary of Key Points Core Viewpoint - The report details the changes in issued shares and treasury shares of Lee's Pharmaceutical Holdings Limited, highlighting a decrease in the total issued shares from 307,052,417 to 299,807,117 between April 30, 2025, and May 14, 2025, due to share repurchases [2]. Group 1: Share Issuance and Changes - The total issued shares (excluding treasury shares) as of April 30, 2025, were 307,052,417 [2]. - As of May 14, 2025, the total issued shares decreased to 299,807,117, indicating a reduction of 7,245,300 shares [2]. - The report confirms that the changes in share capital have been authorized by the board and comply with applicable listing rules and regulations [3]. Group 2: Treasury Shares - The report does not indicate any changes in treasury shares, which remained at 604,293,313 as of both April 30, 2025, and May 14, 2025 [2]. - The company has not yet canceled the repurchased shares as of the reporting date [3]. Group 3: Compliance and Authorization - The report confirms compliance with all relevant listing rules, legal requirements, and regulatory provisions regarding the issuance and repurchase of shares [3]. - All necessary documentation and approvals related to the share transactions have been completed and filed as required [3].